China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type China Medical System Holdings Ltd. Jan 09, 2025 09:00 JST Read More
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease Eisai Jan 07, 2025 08:14 HKT/SGT Read More
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year Olympus Dec 24, 2024 10:00 HKT/SGT Read More
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases Eisai Dec 23, 2024 16:22 HKT/SGT Read More
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024 NEC Corporation Dec 12, 2024 15:27 HKT/SGT Read More
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia Eisai Dec 11, 2024 13:45 HKT/SGT Read More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China China Medical System Holdings Ltd. Dec 09, 2024 14:00 JST Read More
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico Eisai Dec 05, 2024 10:22 HKT/SGT Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia China Medical System Holdings Ltd. Dec 02, 2024 22:30 JST Read More
Honda Introduces AI-powered Social Robot, Haru, to University Hospital in Spain Honda Motor Co, Ltd Dec 02, 2024 22:08 HKT/SGT Read More
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea Eisai Nov 28, 2024 15:26 HKT/SGT Read More
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan Eisai Nov 26, 2024 14:50 HKT/SGT Read More
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Eisai Nov 20, 2024 10:51 HKT/SGT Read More
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Eisai Nov 20, 2024 09:24 HKT/SGT Read More
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Olympus Nov 19, 2024 14:30 HKT/SGT Read More
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment) Eisai Nov 15, 2024 16:33 HKT/SGT Read More
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Eisai Nov 15, 2024 13:31 HKT/SGT Read More
Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism Mitsubishi Corporation Nov 15, 2024 11:32 HKT/SGT Read More
ニュートン バイオキャピタル、⽇本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、⽇本初の投資を発表 Newton Biocapital Nov 14, 2024 11:00 JST Read More
